Literature DB >> 17521012

Diagnosis and minimally invasive resection of an insulinoma: report of an unusual case and review of the literature.

Bruce J Gutelius1, Mary T Korytkowski, Sally E Carty, Giselle G Hamad.   

Abstract

Insulinomas are rare endocrine tumors that are usually diagnosed by inappropriate elevations in insulin and C-peptide during hypoglycemia. We report a case of a surgically confirmed insulinoma diagnosed by a mild elevation in proinsulin with suppressed insulin and C-peptide at the time of hypoglycemia during a supervised fast. A supervised fast with serial measurements of plasma glucose, insulin, and C-peptide was performed in a patient with documented hypoglycemia. Proinsulin was measured at the beginning and end of the fast. Tumor localization was accomplished with spiral CT, magnetic resonance imaging, and endoscopic ultrasound. Minimally invasive tumor resection was performed. The presence of an insulinoma was confirmed on the basis of a minimally elevated proinsulin level with a suppressed insulin level at the time of symptomatic hypoglycemia. Tumor resection was performed without complications, resulting in resolution of the hypoglycemia. This case demonstrates the importance of measuring proinsulin as a routine component of the 72-hour fast for detection of an insulinoma. Even mild elevations in circulating proinsulin can be an independent indicator of aberrant insulin secretion during hypoglycemia. Once the diagnosis of insulinoma is made and tumor localization is achieved, minimally invasive tumor resection is a safe and effective treatment modality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521012

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Setting the bar for laparoscopic resection of sporadic insulinoma.

Authors:  Melanie L Richards; Geoffrey B Thompson; David R Farley; Michael L Kendrick; John F Service; Adrian Vella; Clive S Grant
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

Review 2.  A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.

Authors:  Timothy D Murtha; Beatrice C Lupsa; Sachin Majumdar; Dhanpat Jain; Ronald R Salem
Journal:  J Gastrointest Surg       Date:  2017-05-16       Impact factor: 3.452

Review 3.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 4.  Growth factor control of pancreatic islet regeneration and function.

Authors:  Anke Assmann; Charlotte Hinault; Rohit N Kulkarni
Journal:  Pediatr Diabetes       Date:  2008-09-19       Impact factor: 4.866

Review 5.  Pancreatic insulinomas: Laparoscopic management.

Authors:  Pantelis T Antonakis; Hutan Ashrafian; Alberto Martinez-Isla
Journal:  World J Gastrointest Endosc       Date:  2015-11-10

6.  Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience.

Authors:  Andrey Germanovich Kriger; Stanislav Valer'evich Berelavichus; Ayrat Radikovich Kaldarov; Vladimir Igorevich Panteleev; David Semjonovich Gorin; Rimma Sangaevna Dugarova; Marina Yur'evna Yukina
Journal:  Gastrointest Tumors       Date:  2019-08-13

7.  Metastatic Insulinoma Presenting With Postprandial Hypoglycemia.

Authors:  Monique Debrah Maher; Dimpi Nitin Desai; Mandeep Bajaj
Journal:  AACE Clin Case Rep       Date:  2022-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.